多肽是由肽(酰胺)键连接的短链氨基酸单体。一个氨基酸的羧基与另一个氨基酸的氨基反应形成共价化学键。
-
默认
常备现货
-
纯度
- 请选择
- 99+%
- 99%
- 98+%
- 98%
- 97+%
- 97%
- 96+%
- 96%
- 95+%
- 95%
- 93%
- 90+%
- 90%
规格
- 请选择
- 1mg
- 2mg
- 5mg
- 10mg
- 25mg
- 50mg
- 100mg
- 250mg
- 1g
- 5g
- 10g
- 25g
- 100g
- 500g
- 1000g
- 1kg
清空选项
-
(S)-2-((R)-2-Amino-4-methylpentanamido)-3-(4-hydroxyphenyl)propanoic acid hydrate
(S)-2-((R)-2-氨基-4-甲基戊酰胺基)-3-(4-羟基苯基)丙酸水合物
-
BD1265043303-29-598%
-
¥341.001g
-
(S)-2-(2-Aminoacetamido)propanoic acid
(S)-2-(2-氨基乙酰氨基)丙酸
-
BD1322753695-73-698%
-
¥1320.005g
-
(S)-2-(2-((S)-1-((S)-1-((S)-2-Amino-5-guanidinopentanoyl)pyrrolidine-2-carbonyl)pyrrolidine-2-carboxamido)acetamido)-3-phenylpropanoic acid
(S)-2-(2-((S)-1-((S)-1-((S)-2-氨基-5-胍基戊酰基)吡咯烷-2-羰基)吡咯烷-2-甲酰胺)乙酰胺)-3-苯基丙酸
-
BD13268423815-89-698%
-
¥401.0025mg
-
(S)-2-((S)-2-Amino-3-carboxypropanamido)-4-methylpentanoic acid
(S)-2-((S)-2-氨基-3-羧基丙酰胺基)-4-甲基戊酸
-
BD1327443062-14-495%
-
¥1546.001g
-
(S)-2-((S)-2-Amino-3-(1H-imidazol-4-yl)propanamido)-3-hydroxypropanoic acid
(S)-2-((S)-2-氨基-3-(1H-咪唑-4-基)丙酰胺基)-3羟基丙酸
-
BD13353821438-60-895%
-
¥2572.001g
-
(S)-2-((S)-2-Amino-3-methylbutanamido)pentanedioic acid
(S)-2-((S)-2-氨基-3-甲基丁胺基)戊二酸
-
BD1057283062-07-597%
-
¥606.00100mg
-
(S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-methylpentanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid
(S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-4-甲基戊酰基)-2,2-二甲基恶唑烷-4-羧酸
-
BD300020339531-50-998%
-
¥519.001g
-
(S)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)propanoyl)-2,2-dimethyloxazolidine-4-carboxylic acid
(S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(4-(叔丁氧基)苯基)丙酰基)-2,2-二甲基恶唑烷-4-羧酸
-
BD300048878797-09-298%
-
¥3555.005g
-
Fmoc-Lys(Boc)-Thr[Psi(Me,Me)Pro]-OH
(4S,5R)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-6-((叔丁氧羰基)氨基)己酰基)-2,2,5-三甲基恶唑烷-4-羧酸
-
BD300054911838-56-798+%
-
¥2858.005g
-
(4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-3-(4-(tert-butoxy)phenyl)propanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid
(4S,5R)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(4-(叔丁氧基)苯基)丙酰基)-2,2,5-三甲基恶唑烷-4-羧酸
-
BD300055920519-31-998%
-
¥2175.005g
-
(4S,5R)-3-((S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(tert-butoxy)-4-oxobutanoyl)-2,2,5-trimethyloxazolidine-4-carboxylic acid
(4S,5R)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-4-(叔丁氧基)-4-氧代丁酰基)-2,2,5-三甲基恶唑烷-4-羧酸
-
BD300056920519-32-095%
-
¥2621.005g
-
Fmoc-Leu-Thr[Psi(Me,Me)Pro]-OH
(4S,5R)-3-((((9H-芴-9-基)甲氧基)羰基)-L-亮氨酰)-2,2,5-三甲基恶唑烷-4-羧酸
-
BD300059955048-89-298+%
-
¥706.001g
-
(S)-2-((S)-2-Aminopropanamido)-3-phenylpropanoic acid
(S)-2-((S)-2-氨基丙酰胺基)-3-苯基丙酸
-
BD141313061-90-398+%
-
¥353.00250mg
-
(S)-2-((S)-2-Amino-3-(1H-imidazol-4-yl)propanamido)propanoic acid
(S)-2-((S)-2-氨基-3-(1H-咪唑-4-基)丙胺基)丙酸
-
BD701516874-75-295%
-
¥1604.001g
-
(S)-2-(3-Acetamidopropanamido)-3-(1H-imidazol-4-yl)propanoic acid
(S)-2-(3-乙酰氨基丙酰胺)-3-(1H-咪唑-4-基)丙酸
-
BD3410456353-15-297%
-
¥480.005g
-
(S)-12-Benzyl-2,2-dimethyl-4,7,10,13-tetraoxo-3-oxa-5,8,11,14-tetraazahexadecan-16-oic acid
(S)-12-苄基-2,2-二甲基-4,7,10,13-四氧代-3-氧杂-5,8,11,14-四氮杂十六烷-16-酸
-
BD725264187794-49-699.9%
-
¥2031.001g
-
(S)-1-((S)-2-((Methoxycarbonyl)amino)-3-methylbutanoyl)pyrrolidine-2-carboxylic acid
(S)-1-((S)-2-((甲氧基羰基)氨基)-3-甲基丁酰基)吡咯烷-2-羧酸
-
BD750934181827-47-495%
-
¥118.0010g
-
Fmoc-Ser(tBu)-Ser(Psi(Me,Me)pro)-OH
(S)-3-((S)-2-((((9H-芴-9-基)甲氧基)羰基)氨基)-3-(叔丁氧基)丙酰基)-2,2-二甲基恶唑烷-4-羧酸
-
BD2999541000164-43-197%
-
¥2287.005g
-
Glucagon-like peptide 2
Glucagon-like peptide 2游离态
-
BD0111823089750-15-299%
-
¥1552.001mg